NSB — Neuroscientific Biopharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- AU$7.66m
- AU$3.17m
- AU$2.39m
- 65
- 91
- 68
- 85
Annual cashflow statement for Neuroscientific Biopharmaceuticals, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | 0.036 | 0.028 | 0.068 | 0.108 | 0.135 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -2.28 | -2.6 | -6.94 | -2.3 | 0.044 |
| Capital Expenditures | -0.002 | -0.03 | -0.004 | 0 | -0.002 |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | -0.002 | -0.03 | -0.004 | 0 | -0.002 |
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 0.961 | 13.5 | 0 | 0 | — |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1.32 | 10.9 | -6.95 | -2.3 | 0.042 |